Skip to main content

Table 1 Characteristics of the studies included in the meta-analysis

From: Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis

Author Year Country Ethnicity Follow-up (months) Treatment Age (years) No. of patients Stage Cut-off value Survival analysis Analysis NOS
score
Temraz 2014 Lebanon Caucasian 24 Mixed 65 (43–88) 68 Mixed 2.81 OS/RFS UV 8
Lee 2015 UK Caucasian NA Surgery 75 (65–81) 226 Early 1.8 OS MV 7
Zhang 2015 China Asian 50.8 Mixed 65 (30–78) 124 Mixed 4 OS MV 8
Yoshida 2015 Japan Asian 72 (27.6–111.6) Mixed 72 (43–91) 181 Mixed 3.51 OS MV 7
Lucca 2016 Austria Caucasian NA Surgery 68 (61–74) 310 Early 3.3 OS MV 6
D’Andrea 2017 Austria Caucasian 42.4 (18.3–85.1) Surgery 67 (60–73) 4198 Mixed 3.5 OS/RFS/CSS MV 8
Miyake 2017 Japan Asian 22 (10–64) Mixed 72 (61–77) 117 Mixed 3.3 OS/CSS UV 6
Rajwa 2018 Poland Caucasian 14 (7–40) Surgery NA 144 Mixed 2.44 OS/CSS MV 8
Wang 2018 China Asian NA Mixed 63 (20–85) 270 Early 4 RFS UV 7
  1. Abbreviations: OS overall survival, RFS recurrence-free survival, CSS cancer-specific survival, MV multivariate, NA not available